RecruitingNot ApplicableNCT06385223

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression: a Double Blind, Randomized Controlled Trial


Sponsor

Institute of Mental Health, Singapore

Enrollment

70 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The Investigators propose to carry out a randomized, double-blind trial to compare the clinical efficacy of an individualized connectome-guided accelerated iTBS vs an anatomically-guided (Beam F3) accelerated iTBS. The study team will recruit both inpatients and outpatients who had been referred for TMS for the treatment of depression.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a personalized, brain-scan-guided brain stimulation treatment called Intermittent Theta Burst Stimulation (iTBS) — a form of transcranial magnetic stimulation — for people with depression that has not responded well to antidepressants. **You may be eligible if...** - You are 21 or older - You have been diagnosed with a Major Depressive Episode (DSM-5 criteria) - Your depression score is 20 or above on a standard rating scale - You have tried at least one antidepressant for at least 4 weeks without adequate benefit **You may NOT be eligible if...** - You have a psychotic disorder - You have drug or alcohol dependence in the past 3 months - You are at high risk of suicide requiring urgent treatment - You have epilepsy or significant neurological disease - You have a pacemaker, cochlear implant, or metal in your skull - You are pregnant or cannot undergo an MRI Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBeam F3 targeted accelerated iTBS

Magpro X100, Axilium Cobot, Localite camera

DEVICEIndividualized connectome-guided accelerated iTBS

Magpro X100, Axilium Cobot, Localite camera


Locations(1)

Institute of Mental Health

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06385223


Related Trials